Cargando...
Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC
Non-small cell lung cancer (NSCLC) represents the paradigm of personalized treatment of human cancer. Several oncogenic druggable alterations have been so far identified, with anaplastic lymphoma kinase (ALK) gene rearrangements being one of the newest and most appealing. Presence of ALK fusions is...
Gardado en:
| Publicado en: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5233871/ https://ncbi.nlm.nih.gov/pubmed/28149753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2016.12.05 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|